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Figure 2.
Further, chondrocytes cultured with physiological O2 + ROS exhibited
increased OCRs. The differences were accounted for by increased total
protein×cell−1. Although proliferation was strongly affected, cells from
20% O2 did not recover when transferred to 2% O2.
Conclusions: Oxidative capacity and mitochondrial biosynthesis in-
creased within days of transfer to monolayer, associated with increased
oxidative stress with both culture duration and incubator O2. Maintenance
under physiological oxygen only partially limited the induction of an
oxidative metabolism and oxidative stress, reducing both parameters by
half. Exposure of low-O2 cultures to an exogenous ROS also induced
an oxidative metabolism. This evidence supports the stated hypothesis.
Further we demonstrate that cultures in 20% O2 could not recover their
metabolism when transferred to 2% O2 for 7 days.
499 OPTIMIZING COLLAGEN-GAG SCAFFOLDS FOR CARTILAGE
TISSUE ENGINEERING APPLICATIONS
H. Baskaran, B.L. Kienitz, W-H. Liang, K. Penick, J.F. Welter. Case
Western Reserve University, Cleveland, OH, USA
Purpose: Porous collagen biomaterials hold great potential for use
as scaffolds in cartilage tissue-engineering. Others have developed
collagen-based constructs with tunable properties of volume fraction and
pore-size distribution. In this work, we discuss the development of a new
process that allows for tuning of these properties, and the mechanical
strength of the scaffold towards cartilage tissue engineering (TE).
Methods: Collagen-chondroitin-6-sulfate (CG) scaffolds of varying prop-
erties were formed by concentrating a CG suspension in acetic acid
through centrifugation, and subsequent lyophilization. The centrifugal
force and the ﬁnal composition were varied. The morphology of the
resulting scaffolds was assessed by measuring the pore size, area, and
cell adhesion area. The water-uptake and mechanical properties of the
scaffolds were also assessed. For cartilage TE, human bone marrow-
derived mesenchymal stem cells (MSCs) obtained from 4 healthy adult
donors, were vacuum-seeded into the scaffolds at a density equal to the
void volume of the scaffold. The scaffolds were cultured in a bioreactor
in chondrogenic medium.
Results: Our results show that the CG suspensions concentrated to
as high as 5.6 times the starting value within 20 minutes after the
introduction of the centrifugal force. Increasing the centrifugation duration
beyond 20 minutes had no signiﬁcant effect on the ultimate density of CG
suspensions. Morphological analyses showed that scaffolds with greater
CG density were characterized by increased number of pores/area, and
decreased pore size. In addition, the cell seeding area increased with the
CG density. The modulus of elasticity values of the concentrated scaffolds
were an order of magnitude (as high as 3MPa) greater than that of the
unconcentrated scaffolds (Figure 1). To assess the scaffold’s compatibility
for cartilage tissue-engineering applications, histology, DNA content and
glycosaminoglycan (GAG) content of the constructs were assessed after
1 day and 3 weeks of culture. Cross-sections of the constructs harvested
immediately after seeding show cells in the scaffold voids throughout
the entire thickness of the scaffold, suggesting good interconnectivity of
the scaffold pores. Cells were viable for the duration (3 weeks) of the
experiment, and the GAG content increased from ~240 (day 1) to 1900
(day 21) mg/scaffold. After 3 weeks of culture, the void spaces had been
ﬁlled with cell-derived ECM which was positive for proteoglycans, and
collagen type II. We detected no type I and only trace type X.
Conclusions:We have developed a new process to obtain collagen-GAG
scaffolds for cartilage tissue engineering. The new process allows for
tuning of not only the pore size and distribution but also the mechanical
properties of the scaffold material thus making the resultant scaffolds
particularly suitable for cartilage TE. The scaffolds’ physical properties
allow for easy manipulation; they can easily and efﬁciently be seeded
with MSCs. The scaffolds support the differentiation of MSCs leading to
ECM production.
The harsh mechanical environment of the joint requires that cartilage
constructs should be able to match the mechanical properties of the
native tissue. In vitro conditioning can lead to increased ECM content
of the construct thereby increasing the chances of survival in vivo.
The scaffolds developed in this work are from natural biomaterial, have
superior mechanical properties, can allow for conditioning in vivo, and
reduce/eliminate in vitro conditioning.
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Purpose: Cell-based tissue engineering offers a promising means of
replacing or repairing lost or damaged tissues. Osteoarthritis (OA), or
degenerative joint disease, is the most prevalent of all musculoskeletal
diseases and is characterised by the progressive destruction of articular
cartilage. As mature articular cartilage has a very limited regenerative
potential, treatment options for OA are limited and ultimately the disease
leads to total joint arthroplasty. Mesenchymal stem cells (MSCs) offer new
possibilities for the treatment of OA by contributing to the regeneration or
maintenance of connective tissues. The aim of this study was to evaluate
various strategies to promote homing of MSCs to ﬁbrillated cartilage using
a human OA cartilage explant culture model to advance tissue repair.
Methods: Preliminary experiments were performed to establish the cul-
ture system using cartilage explants from goat medial tibial plateau
(MTP). Full thickness cartilage explants (1−2mm thick and 2mm diame-
ter) were obtained from the goat MTP and the MTP and femoral head of
humans after total knee and hip arthroplasty, respectively. Explants were
placed in 10% FCS containing media for 48 h at 37ºC and subsequently
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cultured in chondrogenic media without TGF-b3 (ICM) for 24 h. Human
MSCs obtained from healthy donors were labelled with Cell Tracker Red
and DAPI, and added to explants at a cell density of 1−4×106 cells/ml for
20–120min at 37ºC with agitation. Unattached cells were removed and
explants were either processed immediately or treated with chondrogenic
media containing TGF-b3 (CCM) or ICM for 14 days. Proteoglycan (GAG)
levels were measured by Alcian Blue and PicoGreen assays and GAG
synthesis determined using S35 incorporation. Cartilage disks incubated
without cells were used as controls. Explants were pre-treated with 0.25%
trypsin/EDTA and collagenase (1mg/ml), 0.25% trypsin/EDTA alone,
collagenase alone and PBS alone. Formalin-ﬁxed, parafﬁn-embedded
sections were stained with Toluidine blue or processed for ﬂuorescence
microscopy. Bound cells were quantiﬁed using a systematically random-
ized stereological method that enabled unbiased estimation of numerical
density.
Results: Osteoarthritic goat cartilage explants were used to establish the
explant culture system. Mean accumulated GAG/DNA and proteoglycan
release was consistent in explants cultured in serum-containing media,
CCM and ICM over 14 days. Sulphate incorporation was also similar
in serum-containing media and CCM but signiﬁcantly lower in explants
cultured in ICM over 14 days. Maximum binding of MSCs to OA car-
tilage was observed in a free ﬂoating system with cartilage from the
tibial plateau. At lower attachment times (20min), a density-dependent
increase in binding was observed and the level of cell adherence was
determined using stereological assessment. Explant exposure to trypsin
resulted in increased MSC binding while treatment with collagenase had
no effect. Bound cells survived and started to differentiate to promote
surface repair of the cartilage when exposed to CCM for 14 days.
Conclusions: This system of explant culture and cell attachment allows
evaluation of the ability of targeted cells to repair the cartilage surface.
MSC binding to OA cartilage was dependent on numerous factors includ-
ing culture conditions, cell number and exposure time. Adherent MSCs
underwent a morphological change and elaborated a cartilaginous matrix.
Strategies for stem cell-mediated repair of ﬁbrillated cartilage may require
targeting of stem cells to damaged cartilage in early OA.
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Purpose: The aim of this study was to test the hypothesis that senes-
cence contributes to a decreased capacity of mesenchymal stem cells
(MSCs) to self-renew in osteoarthritis (OA) for normal tissue homeostasis
and to study the mechanisms by which this may occur. To this end, we
examined factors which contribute to cellular senescence, such as the
expression of cell cycle inhibitors (p16, p21 and p27) and the telomerase
catalytic component (hTERT), telomerase activity and telomere length.
Methods: MSCs were isolated from the bone marrow of OA patients
undergoing hip and knee replacement surgery and normal unaffected
donors. All procedures were performed with informed consent and ap-
proved by the Clinical Research Ethical Committee at University College
Hospital, Galway. Isolated MSCs were subjected to osteogenic, chondro-
genic and adipogenic assays and doubling times for OA and control MSCs
recorded. Genomic DNA and RNA was isolated from the MSCs and
used to determine telomere length by the telomere length assay (Roche)
and expression of cell cycle inhibitors and hTERT using real-time PCR,
respectively. Protein was also extracted for assessment of telomerase
activity using the ELISA-based TRAP assay and determination of cell
cycle inhibitor levels by Western blotting.
Results: OA and control MSCs differentiated along the adipo-, osteo-
and chondrogenic pathways under appropriate stimulation. Population
doublings of OA (6.4±2.5 days) and control MSCs (3.85±.212 days)
were measured. Protein (10mg) was extracted from MSC samples and
subjected to the PCR-based TRAP assay to measure telomerase activity.
Both OA and control MSCs were negative for telomerase relative to
identical amount of protein extracted from the Jurkat T cell line, although
trends point to higher telomerase activity in the control compared to OA.
Genomic DNA was isolated from both groups and analysed for telom-
ere length using the TeloTAGGG Telomere Length Assay, with results
suggesting no difference in telomere length between MSCs from control
and OA MSCs. Total RNA was extracted from both groups, converted
to cDNA and analysed for relative p16, p21, p27 and hTERT gene
expression using SYBR green real-time quantitative PCR chemistry and
the 2-DDCT method. p16 gene expression was slightly reduced in OA
relative to control samples while p21 expression was increased 2-fold. p27
expression was unchanged and hTERT was not detected in OA MSCs or
controls. Increased protein levels of p21 in OA MSCs were detected by
Western blotting.
Conclusions: The data does not suggest an association of telomerase-
related cellular senescence and the slower growth kinetics seen in MSCs
isolated from osteoarthritic patients, due to the low telomerase activity,
lack of hTERT expression and identical telomere length in OA and control
MSCs. However, the increased p21 expression along with slightly reduced
p16 levels in OA relative to controls is interesting and warrants further
investigation. p16 acts through the cyclin dependent kinases to maintain
normal cells in G1 growth arrest while p21 is upregulated by p53 and
plays an important role in inducing cell cycle arrest. The increased p21
expression observed in this study may indicate increased senescence of
stem cells in OA.
502 CHONDROGENESIS FROM ADIPOSE TISSUE-DERIVED
MESENCHYMAL STEM CELLS
G-I. Im, H-J. Kim. Dongguk University Int’l Hospital, Goyang, REPUBLIC
OF KOREA
Purpose: While pioneering studies demonstrated the chondrogenic po-
tential of adipose-tissue derived mesenchymal stem cells (ATMSCs),
some subsequent examinations have reported that ATMSCs have an infe-
rior chondrogenic potential to that of bone marrow derived mesenchymal
stem cells (BMMSCs).
This study examined the combination of growth factors that would induce
effective chondrogenesis from ATMSCs that is comparable to BMMSCs.
Methods: Human mesenchymal stem cells were isolated from bone
marrow (BMMSCs), and adipose tissue (ATMSCs). These cells were
characterized by ﬂow cytometry analysis for CD34, CD45, CD73, and
CD166. Chondrogenesis was induced by culturing the ATMSCs in pellets
with the following growth factors: #1 without growth factors (negative
control): #2, 5 ng/ml of TGF-b2; #3, 100 ng/ml of BMP-2; #4, 100 ng/ml of
BMP-6; #5, 100 ng/ml of BMP-7; #6, 5 ng/ml of TGF-b2 and 100 ng/ml of
BMP-2; #7, 5 ng/ml of TGF-b2 and 100 ng/ml of BMP-6; and #8, 5 ng/ml
of TGF-b2 and 100 ng/ml of BMP-7. BMMSCs cultured under the same
condition as in #2 were used as the negative and positive controls. After
4 weeks in-vitro culture, the pellets were harvested for DNA quantiﬁcation,
analysis of the glycosaminoglycan contents, reverse transcription and
real-time PCR for collagen type I (Col1A1), collagen type II (Col2A1),
collagen type X (Col10A1), sox-9. Safranin-O and immunohistochemical
staining for type II collagen as well as histological analysis were carried
out, and semiquantitative scoring was performed based on the histological
ﬁndings.
Results: After 4 weeks of in-vitro culture, GAG assay, real-time RT-PCR
and histological ﬁndings demonstrated that culturing the ATMSCs using a
combination of 5 ng/ml of TGF-b2 and 100 ng/ml of BMP-7 most effectively
induced chondrogenesis.
Conclusions: The overall results suggest that appropriate combinations
of growth factors can overcome the intrinsic inferior chondrogenic poten-
tials of ATMSCs to some degree.
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Purpose: The use of chondrocytes graft in a gel allows to simplify the
surgical technique with no leakage risk and to propose an implant of
differentiated chondrocytes distributed homogeneously throughout the
condyle lesion.
Methods: A phase II prospective study of this graft in a unique os-
teochondral lesion of the femoral condyle reaching less than 5 cm2
surface, grade 3 and 4 (ICRS) invalidating (subjective IKDC Score <55),
of traumatic origin or osteochondritis dissecans has been conducted by
4 French centers from August 2002 to August 2006, with a follow up of
24 months. The mean criterion was the evolution of the subjective IKDC
score (If 13 patients presented an evolution of 10 points, the treatment
